No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
769 |
4. Check minimum number of eventsNone |
769 |
5. Include endpoints |
769 |
6. Filter based on genotype QC (FinnGen only) |
613 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
- Human immunodeficiency virus [HIV] disease
- Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo
- Human immunodeficiency virus [HIV] disease resulting in other conditions
- Unspecified human immunodeficiency virus [HIV] disease, including avohilmo
- Unspecified human immunodeficiency virus [HIV] disease
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 613 | 128 | 485 |
| Unadjusted period prevalence (%) | 0.19 | 0.05 | 0.22 |
| Median age at first event (years) | 40.35 | 40.51 | 40.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 734
- Matched controls
- 7340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
307.7
640
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
28.6
307.7
409
309
WW200
NOMESCO Finland
Immunization
267.4
307.7
548
80
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
307.7
394
*
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
255.6
230
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
19.3
247.8
217
156
Z3231
NOMESCO Finland
Registered nurse
10.3
224.7
487
1179
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
207.4
189
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
12.2
204.3
247
294
Z2221
NOMESCO Finland
Medical doctor
6.1
132.2
393
1170
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
325.5
86.7
86
*
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
81.8
77
*
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
14.1
77.0
73
57
A51.0
ICD-10 Finland
Primary genital syphilis
400.9
74.1
73
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
6.6
72.6
130
231
Y25
ICPC
Fear sexually transm disease male
7.7
62.9
94
137
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
60.2
57
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
11.2
58.7
64
62
A63.0
ICD-10 Finland
Anogenital (venereal) warts
7.2
58.4
93
145
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
128.1
55.7
59
5
WYA30, ,
SPAT
22.8
52.8
39
18
A54.5
ICD-10 Finland
Gonococcal pharyngitis
186.2
50.6
52
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
49.1
440
2383
A51.9
ICD-10 Finland
Early syphilis, unspecified
498.8
47.9
47
*
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
4.3
44.8
134
365
A53.9
ICD-10 Finland
Syphilis, unspecified
453.3
43.7
43
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.2
43.1
131
361
EB1AA, ,
SPAT
4.7
42.3
108
260
C10AA07
ATC
rosuvastatin; oral
2.8
41.3
343
1737
WX110, ,
SPAT
4.7
39.1
99
236
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.7
38.7
46
50
ZX114
NOMESCO Finland
Intramuscular
11.4
35.8
38
35
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
34.7
33
*
K02.9
ICD-10 Finland
Dental caries, unspecified
8.4
34.4
46
58
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
80.2
34.2
38
5
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
31.9
101
284
F43.29
ICD-10 Finland
Adaptation disorder UNS
6.4
30.2
52
87
TAB00
NOMESCO Finland
Lumbar puncture
4.7
28.4
69
158
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
4.9
27.6
64
141
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.0
27.1
61
131
Z3226
NOMESCO Finland
Physiotherapist
2.8
26.6
163
683
N05CD07
ATC
temazepam; oral
3.5
26.3
97
302
ULA02
NOMESCO Finland
Kolposcopy
4.1
26.2
78
209
R4110
NOMESCO Finland
Physiotherapy
2.4
25.6
243
1252
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.1
25.4
74
195
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
6.7
24.1
39
61
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
23.7
131
517
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.4
23.4
222
1138
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
23.0
22
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.0
22.3
49
103
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
22.0
21
*
Z2446
NOMESCO Finland
Social worker
3.6
22.0
78
236
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
7.2
21.8
33
48
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
21.3
136
577
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
35.0
21.2
27
8
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
51.6
21.2
25
5
B90
ICPC
HIV-infection/AIDS
+∞
20.9
20
*
J05AB11
ATC
valaciclovir; oral
2.7
20.9
134
569
Z71.8
ICD-10 Finland
Other specified counselling
2.1
20.8
284
1674
J05AB01
ATC
aciclovir; systemic
2.4
20.6
181
890
ZXE00
NOMESCO Finland
One hour or less
2.1
20.2
293
1762
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
20.1
179
885
R50.9
ICD-10 Finland
Fever, unspecified
2.5
19.9
144
648
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
205.3
19.6
20
*
D11
ICPC
Diarrhoea
2.7
19.5
120
498
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
19.4
239
1347
K02.2
ICD-10 Finland
Caries of cementum
4.0
19.1
56
148
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
35.4
19.0
24
7
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
18.8
269
1602
WX290, ,
SPAT
4.1
18.5
52
133
Z3232
NOMESCO Finland
Midwife
3.5
17.8
64
195
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
17.8
17
*
A01AB04
ATC
amphotericin B; local oral
5.1
17.7
38
78
Z01.2
ICD-10 Finland
Dental examination
1.9
17.1
379
2605
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.4
17.1
139
657
N05CF01
ATC
zopiclone; oral
2.0
16.8
238
1400
Y71
ICPC
Gonorrhoea male
+∞
16.7
16
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.7
16.5
97
392
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.3
16.2
64
207
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.9
16.0
48
129
P19
ICPC
Drug abuse
6.8
15.8
25
38
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
15.7
123
570
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
15.7
15
*
UJH02
NOMESCO Finland
Anoscopy
3.9
15.4
46
123
A97
ICPC
No disease
2.2
15.4
157
812
B02.9
ICD-10 Finland
Zoster without complication
3.3
15.2
60
194
S02.51
ICD-10 Finland
Fracture of tooth, open
2.6
14.9
98
418
J01MA12
ATC
levofloxacin; systemic
2.2
14.8
144
730
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
14.6
14
*
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
152.9
14.5
15
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
14.2
175
972
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
14.0
249
1566
ZXD35
NOMESCO Finland
Usual procedure
4.2
14.0
38
95
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
13.7
201
1186
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
13.6
13
*
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
13.6
13
*
SPAT1263
SPAT
Sampling
0.4
13.2
98
1908
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
13.2
49
152
TLC02
NOMESCO Finland
Simple extraction of IUD
4.6
13.2
31
69
TQW99
NOMESCO Finland
Other minor procedure on skin
3.7
12.6
41
117
R74
ICPC
Upper respiratory infection acute
1.8
12.5
279
1869
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
13.5
12.5
21
16
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
132.2
12.5
13
*
EB1SA, ,
SPAT
3.0
12.4
58
207
J01MA02
ATC
ciprofloxacin; systemic
1.8
12.4
275
1838
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
47.5
11.9
14
*
EBA00, ,
SPAT
4.1
11.8
33
84
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.7
11.8
67
265
K05.31
ICD-10 Finland
Periodontitis pronounced
2.2
11.6
100
481
N06AB04
ATC
citalopram; systemic
2.0
11.6
149
835
5AB01, ,
NOMESCO Finland
+∞
11.5
11
*
B20.3
ICD-10 Finland
HIV disease resulting in other viral infections
+∞
11.5
11
*
A54.9
ICD-10 Finland
Gonococcal infection, unspecified
+∞
11.5
11
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
11.5
11
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.5
11.5
73
306
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
9.1
11.3
23
26
JN4BD
NOMESCO Finland
Extensive body CT
2.5
11.3
76
327
SPAT1153
SPAT
Removal of sutures
0.4
10.8
57
1290
B17.1
ICD-10 Finland
Acute hepatitis C
28.5
10.8
14
5
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
10.7
134
741
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.1
10.6
44
147
B23.2
ICD-10 Finland
HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
+∞
10.4
10
*
B22.0
ICD-10 Finland
HIV disease resulting in encephalopathy
+∞
10.4
10
*
A52.9
ICD-10 Finland
Late syphilis, unspecified
+∞
10.4
10
*
ZXA05
NOMESCO Finland
Left side
1.9
10.4
156
917
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.5
10.3
25
57
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.5
10.3
100
1795
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.2
10.2
40
129
N05BA04
ATC
oxazepam; oral
1.8
10.1
177
1091
OAA67, ,
SPAT
0.4
10.0
59
1281
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
7.8
10.0
22
29
ZXA00
NOMESCO Finland
Right side
1.8
9.9
167
1017
N05BA01
ATC
diazepam; systemic, rectal
2.1
9.9
99
504
EBA05, ,
SPAT
4.5
9.9
24
55
M01AC06
ATC
meloxicam; systemic, rectal
0.5
9.8
94
1702
-1, ,
NOMESCO Finland
1.7
9.8
254
1749
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
4.2
9.8
26
64
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.0
9.6
43
150
Y70
ICPC
Syphilis male
101.3
9.4
10
*
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
101.3
9.4
10
*
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
9.4
9
*
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
9.4
9
*
B21.0
ICD-10 Finland
HIV disease resulting in Kaposi sarcoma
+∞
9.4
9
*
T74.1
ICD-10 Finland
Physical abuse
3.7
9.3
29
80
KMAK, ,
NOMESCO Finland
1.6
9.3
402
3137
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.4
9.3
49
1115
OAB43, ,
SPAT
0.6
9.2
167
2504
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
9.1
77
366
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
9.1
99
520
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.9
9.1
140
828
WNF00
NOMESCO Finland
Infection source and contact determination
24.3
8.9
12
5
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
8.1
8.9
19
24
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.1
8.8
90
461
SPAT1301
SPAT
No procedures
0.4
8.8
54
1159
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
9.6
8.8
17
18
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
8.5
65
296
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.2
8.4
76
371
C10AA01
ATC
simvastatin; oral
0.5
8.4
80
1461
B20.7
ICD-10 Finland
HIV disease resulting in multiple infections
+∞
8.3
8
*
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
8.3
8
*
O98.3
ICD-10 Finland
Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium
+∞
8.3
8
*
B16.9
ICD-10 Finland
Acute hepatitis B without delta-agent and without hepatic coma
+∞
8.3
8
*
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
8.3
8
*
A51.4
ICD-10 Finland
Other secondary syphilis
+∞
8.3
8
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
8.3
8
*
D07AB08
ATC
desonide; topical
2.1
8.3
83
422
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
8.2
64
1254
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
8.1
140
855
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
11.9
8.1
14
12
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.4
8.0
18
25
N07BA03
ATC
varenicline; oral
2.3
8.0
58
259
A23
ICPC
Risk factor NOS
2.0
7.9
85
444
RD210, ,
NOMESCO Finland
4.7
7.9
18
39
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
13.2
7.9
13
10
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
7.9
58
260
Z2445
NOMESCO Finland
Psychologist
2.8
7.9
40
150
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
11.0
7.8
14
13
OAA80, ,
SPAT
0.4
7.8
41
938
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.9
7.7
35
123
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.7
7.7
42
163
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.5
7.7
47
193
SPAT1249
SPAT
Treatment-related counselling outside office
0.5
7.7
100
1666
B59
ICD-10 Finland
Pneumocystosis
45.5
7.7
9
*
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
4.6
7.7
18
40
SPAT1310
SPAT
Counselling related to known health issue
0.5
7.6
67
1265
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.5
7.6
26
77
N87.1
ICD-10 Finland
Moderate cervical dysplasia
6.3
7.6
19
31
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
7.6
204
1404
A07AA02
ATC
nystatin; oral
2.8
7.5
36
131
LDA10
NOMESCO Finland
Curettage of cervix uteri
3.6
7.5
24
68
WX892
NOMESCO Finland
Monitored bed care
2.2
7.4
60
280
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.7
7.4
39
149
R06AE07
ATC
cetirizine; oral
1.5
7.3
288
2161
A53.0
ICD-10 Finland
Latent syphilis, unspecified as early or late
+∞
7.3
7
*
D06BB04
ATC
podophyllotoxin; topical
2.2
7.3
59
276
B07.9
ICD-10 Finland
Verruca simplex
2.7
7.2
38
145
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.7
7.2
166
1096
F31
ICD-10 Finland
Bipolar affective disorder
4.6
7.2
17
38
S29
ICPC
Skin symptom/complaint other
1.8
7.2
126
772
WZC30, ,
SPAT
0.2
7.2
6
324
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
7.1
57
265
M01AH05
ATC
etoricoxib; oral
0.7
7.1
327
4034
ZXD20
NOMESCO Finland
Day surgery
1.9
7.0
86
471
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.4
6.9
48
210
TGC00
NOMESCO Finland
Bronchial lavation
3.3
6.9
26
82
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.9
250
1839
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
11.1
6.8
12
11
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
6.8
48
212
EB1HA, ,
SPAT
3.4
6.7
24
73
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
6.7
50
1001
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
6.6
72
378
EB4VA, ,
NOMESCO Finland
0.5
6.6
46
946
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
4.2
6.6
17
41
D19
ICPC
Teeth/gum symptom/complaint
1.5
6.5
230
1675
SPAT1312
SPAT
General health counselling
0.5
6.5
72
1263
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.3
6.4
46
204
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.0
6.4
27
91
T40.1
ICD-10 Finland
Poisoning: Heroin
70.4
6.4
7
*
A04.5
ICD-10 Finland
Campylobacter enteritis
7.5
6.4
14
19
Z30.2
ICD-10 Finland
Sterilization
0.2
6.4
11
449
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
5.2
6.4
18
35
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.6
6.3
20
56
J20
ICD-10 Finland
Acute bronchitis
1.9
6.3
77
420
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
5.6
6.3
17
31
D06BB10
ATC
imiquimod; topical
2.5
6.3
38
156
N05AC01
ATC
periciazine; systemic
18.2
6.3
9
5
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.3
6.3
47
213
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
6.3
90
1467
0788A
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-PRIMAARI-INFEKTIO JA OIREETON KANTAJAVAIHE]
+∞
6.3
6
*
B22.7
ICD-10 Finland
HIV disease resulting in multiple diseases classified elsewhere
+∞
6.3
6
*
Z22.9
ICD-10 Finland
Carrier of infectious disease, unspecified
+∞
6.3
6
*
B21.9
ICD-10 Finland
HIV disease resulting in unspecified malignant neoplasm
+∞
6.3
6
*
B20.2
ICD-10 Finland
HIV disease resulting in cytomegaloviral disease
+∞
6.3
6
*
D07AA02
ATC
hydrocortisone; topical
1.8
6.3
98
580
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
6.2
206
1477
XA800
NOMESCO Finland
Neuropsychological investigation
2.4
6.2
43
188
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
6.2
39
163
K12.10
ICD-10 Finland
Stomatitis NOS
12.7
6.1
10
8
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.3
6.1
15
497
R83
ICPC
Respiratory infection other
1.5
6.1
210
1521
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
0.2
6.0
5
269
Z01.7
ICD-10 Finland
Laboratory examination
1.7
6.0
119
753
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.5
6.0
77
1298
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
579
34
802.69
307.65
3.4
2.4
31.39
38.48
%
1.93
120
23
510
602
25.48
307.65
2.6
3.1
27.74
119.79
u/l
0.63
504
524
666
24
2985.57
307.65
19.2
1.2
2812.63
—
u/ml
—
416
0
629
180
238.29
307.65
9.1
3.9
131.86
355.47
mg/l
2.24
613
88
122
15
97.35
233.60
3.6
1.6
—
—
—
0
0
633
2110
15.53
214.56
6.8
3.8
45.72
83.00
e6/l
0.72
303
1499
141
77
22.43
181.97
1.1
1.1
—
—
—
0
0
701
3009
30.58
174.42
21.4
7.0
50.61
57.03
%
55.13
701
2920
701
3054
29.81
170.26
21.6
7.2
35.83
27.96
%
79.44
701
2943
232
329
9.85
165.52
6.6
1.9
—
—
—
0
0
662
2800
14.91
161.30
22.1
11.1
0.00
0.00
e9/l
0.86
638
2303
709
3245
35.79
160.19
21.5
7.0
0.54
0.59
e9/l
10.69
697
2843
710
3315
35.92
155.20
21.5
7.2
2.16
1.92
e9/l
9.62
698
2974
710
3352
35.20
152.20
21.7
7.4
0.18
0.20
e9/l
4.03
697
2983
240
391
8.63
151.36
6.6
2.0
—
—
—
0
0
185
234
10.23
143.28
1.2
1.3
172.51
239.94
miu/ml
1.06
57
103
710
3569
31.26
135.69
22.6
10.7
3.11
4.12
e9/l
50.53
697
3134
663
3165
12.32
130.58
5.8
3.2
0.00
0.00
estimate
0.50
59
640
663
3194
12.12
128.34
5.8
3.2
18.58
7.87
estimate
0.24
62
641
664
3206
12.23
128.15
5.8
3.3
0.00
0.01
estimate
0.79
56
576
577
2801
5.96
98.49
2.4
1.9
1.44
1.53
mmol/l
1.58
564
2462
74
44
18.59
90.45
5.3
2.2
—
—
—
0
0
406
1606
4.42
87.58
3.4
3.1
0.22
0.38
e6/l
0.89
276
1152
292
929
4.56
83.99
5.4
2.0
—
—
—
0
0
278
853
4.64
83.82
4.9
1.9
—
—
—
0
0
285
930
4.37
78.49
2.8
2.9
2.03
1.22
e6/l
0.53
110
434
426
1854
4.09
77.85
3.4
3.2
33.72
76.87
e6/l
0.60
299
1406
106
144
8.43
75.67
2.3
3.2
1.59
2.45
index
0.64
29
88
291
1016
4.09
72.05
2.8
2.7
1.09
0.99
e6/l
0.16
116
518
73
67
11.99
69.58
2.5
1.8
—
—
—
0
0
66
55
13.09
66.82
4.6
2.3
960.41
753.56
e6/l
0.56
54
45
80
97
9.13
62.35
2.1
2.4
33.41
43.50
iu/ml
—
14
9
424
2140
3.32
55.74
4.2
3.6
9.39
9.03
mmol/l
0.66
413
1880
125
272
5.33
55.70
1.4
1.4
—
—
—
0
0
104
227
5.17
45.86
2.5
1.7
—
—
—
0
0
106
247
4.85
43.19
1.2
1.6
0.21
0.26
iu/ml
0.07
54
40
85
168
5.59
41.79
1.1
1.5
151.78
152.70
au/ml
0.02
23
53
46
55
8.86
35.95
5.8
2.6
304.55
222.81
e6/l
1.30
40
48
691
5444
5.60
32.62
33.1
17.3
13.32
13.44
%
1.96
691
5394
36
41
9.18
29.14
6.5
3.1
45.15
22.60
mu/l
2.44
36
41
86
230
4.10
29.05
1.5
1.8
1.24
1.50
g/l
1.82
76
214
247
1240
2.50
27.99
2.8
2.7
3.41
4.55
e6/l
0.75
224
1135
52
99
5.58
26.43
1.2
1.3
—
—
—
0
0
52
99
5.58
26.43
1.2
1.3
—
—
—
0
0
599
4519
2.77
26.02
5.3
4.1
11.06
9.24
mm/h
2.62
591
4317
715
6118
7.52
22.89
27.0
13.1
87.72
88.32
ml/min/173m2
0.40
703
5659
40
68
6.16
22.83
4.0
3.5
—
—
—
0
0
123
492
2.80
21.60
2.4
2.5
76.48
73.74
ml/min/173m2
0.40
63
203
249
1422
2.14
19.57
1.6
1.6
18.74
19.31
nmol/l
0.35
239
1254
672
5727
3.05
16.99
33.7
17.3
336.23
335.07
g/l
2.65
672
5707
33
62
5.53
16.97
1.1
1.0
—
—
—
0
0
25
13
19.86
16.96
1.3
1.3
—
—
—
0
0
707
6302
4.31
14.66
17.2
14.3
25.72
23.37
mg/l
0.89
571
5117
23
35
6.75
14.54
1.0
1.3
2.58
1.99
umol/l
2.25
23
28
79
311
2.73
14.11
1.6
1.7
—
—
—
0
0
22
19
11.90
12.38
2.2
1.7
—
—
iu/ml
—
0
0
56
205
2.87
11.45
2.5
3.3
—
—
—
0
0
123
645
2.09
11.44
1.9
1.9
—
—
—
0
0
75
320
2.50
11.36
1.7
1.3
—
—
—
0
0
107
533
2.18
11.36
1.7
1.6
—
—
—
0
0
126
672
2.06
11.19
1.8
1.9
—
—
—
0
0
43
1117
0.35
11.09
1.5
2.1
3.61
3.81
ratio
0.32
33
898
20
35
5.85
11.05
1.0
1.3
30.55
27.27
umol/l
0.90
20
30
205
1302
1.80
10.70
2.3
2.1
2.41
2.77
mg/l
1.37
182
1154
323
2346
1.67
10.30
2.0
1.9
95.58
96.41
pmol/l
0.14
189
1370
151
885
1.89
10.15
1.9
2.6
2.49
2.33
g/l
2.47
146
836
82
394
2.22
9.48
1.4
1.7
—
—
—
0
0
38
126
3.13
9.25
2.2
1.7
—
—
—
0
0
48
182
2.75
9.21
1.3
1.1
—
—
—
0
0
47
181
2.71
8.77
2.3
8.2
7539.40
249.11
iu/ml
—
5
27
47
183
2.68
8.59
1.3
1.1
—
—
—
0
0
13
8
16.52
8.57
4.0
1.5
—
—
—
0
0
156
2339
0.58
8.42
3.0
3.3
21.30
35.33
ng/l
1.68
78
1505
177
1149
1.71
8.30
3.1
3.9
94.21
646.95
ng/l
3.88
126
856
31
823
0.35
8.20
1.4
1.8
2.96
3.57
mmol/l
3.27
22
597
722
6805
4.73
8.01
33.3
17.5
84.10
79.86
umol/l
4.72
722
6760
175
2487
0.61
7.36
5.2
3.0
0.04
0.01
estimate
0.34
53
544
21
625
0.32
6.96
5.7
6.1
—
—
—
0
0
27
89
3.11
6.68
1.1
1.2
—
—
—
0
0
442
5108
0.66
6.66
3.9
3.6
58.10
51.13
u/l
0.96
424
4938
317
2470
1.50
6.56
8.3
7.9
1.20
1.21
mmol/l
0.17
310
2324
79
435
1.91
6.33
1.7
1.8
0.34
0.33
mg/l
0.09
49
236
20
57
3.58
6.19
4.3
1.9
—
—
—
0
0
137
894
1.65
6.15
1.9
2.0
—
—
—
0
0
97
579
1.78
6.01
3.0
3.7
0.48
1.82
mmol/l
2.21
79
502
118
759
1.66
5.58
2.3
3.4
10.04
8.39
umol/l
0.37
109
688
24
88
2.79
4.98
1.3
1.5
—
—
—
0
0
16
460
0.33
4.97
1.1
1.2
0.89
0.92
g/l
0.09
16
460
16
452
0.34
4.80
1.1
1.1
1.46
1.45
g/l
0.08
16
452
66
376
1.83
4.78
2.4
4.4
78.26
90.65
ng/l
0.82
66
343
133
1856
0.65
4.67
5.2
2.7
0.00
0.03
estimate
0.91
53
512
202
2574
0.70
4.32
2.9
3.4
23.48
21.50
%
0.53
71
944
8
9
8.97
4.29
1.1
3.9
—
—
—
0
0
17
56
3.08
4.26
1.3
1.6
—
—
—
0
0
32
149
2.20
4.08
1.7
1.3
17.04
18.01
e6/l
0.03
23
106
29
130
2.28
4.04
2.1
1.6
—
—
—
0
0
332
2774
1.36
4.03
8.0
8.4
1.20
1.20
mmol/l
0.61
308
2448
14
37
3.84
3.91
3.2
4.8
1.00
0.86
index
0.25
14
37
32
153
2.14
3.84
1.7
1.4
1002.52
2013.76
e6/l
0.31
25
116
270
3229
0.74
3.70
3.7
4.0
1.77
1.71
ug/l
0.07
255
3005
43
233
1.90
3.68
1.6
1.7
72.46
14.46
u/ml
—
8
67
34
172
2.02
3.54
1.1
1.3
548.53
515.60
mg/l
0.17
34
165
169
1290
1.40
3.51
1.6
1.5
—
—
—
0
0
33
166
2.03
3.49
1.3
2.5
55.94
75.49
mg/l
0.21
33
131
14
47
3.02
3.42
3.4
4.4
21.71
12.73
index
1.84
14
37
13
37
3.56
3.41
1.0
1.1
617.62
183.60
iu/ml
1.50
13
37
12
32
3.79
3.40
1.0
1.2
—
—
—
0
0
13
42
3.13
3.38
1.1
1.0
12.16
6.81
iu/ml
—
5
15
8
14
5.76
3.34
1.0
1.9
—
—
—
0
0
82
551
1.55
3.25
3.1
3.2
—
—
—
0
0
301
2537
1.32
3.24
2.3
2.5
72.65
72.73
nmol/l
0.01
292
2369
237
1931
1.34
3.24
3.8
4.3
13.61
9.57
mg/mmol
0.52
165
1299
15
55
2.76
3.17
1.7
2.9
—
—
—
0
0
32
166
1.97
3.14
1.3
2.5
45.19
46.25
mg/l
0.03
32
133
14
50
2.84
3.10
1.4
3.6
1056.50
1366.70
mg
0.37
14
50
8
17
4.75
2.92
1.1
1.2
—
—
—
0
0
29
152
1.95
2.79
1.2
2.2
1.14
1.34
ratio
0.60
12
77
12
297
0.39
2.78
1.8
1.8
—
—
—
0
0
502
4584
1.30
2.77
3.7
3.2
—
—
—
0
0
13
48
2.74
2.73
1.2
1.1
—
—
—
0
0
183
1470
1.33
2.70
1.3
1.3
2.11
2.09
u/ml
0.00
19
458
722
7051
2.47
2.62
36.1
21.1
93.20
90.49
fl
40.05
722
7007
10
260
0.38
2.60
2.8
3.3
25.02
24.78
mmol/l
—
10
252
722
7053
2.45
2.58
37.9
21.9
42.19
42.11
%
0.20
722
7000
32
179
1.82
2.55
1.1
1.2
325.53
246.53
u/ml
0.51
19
114
722
7055
2.43
2.54
36.4
21.3
142.26
142.15
g/l
0.07
722
7009
31
174
1.82
2.46
1.2
1.4
—
—
—
0
0
9
27
3.36
2.40
3.1
1.7
—
—
—
0
0
6
13
4.64
2.27
3.5
1.5
—
—
—
0
0
17
81
2.12
2.14
1.1
1.3
—
87.80
—
0
5
98
743
1.37
2.12
1.8
1.6
840.71
1177.36
nmol/l
4.54
87
596
13
56
2.35
2.05
1.2
1.1
—
—
—
0
0
14
285
0.48
2.03
3.9
3.7
50.54
52.03
%
0.09
14
280
13
57
2.30
1.98
1.2
1.2
—
—
—
0
0
26
149
1.77
1.97
1.0
1.3
—
—
—
0
0
136
1666
0.77
1.96
5.8
3.4
0.00
0.00
estimate
0.80
59
591
13
58
2.26
1.91
1.2
1.2
—
—
—
0
0
13
58
2.26
1.91
1.2
1.2
—
—
—
0
0
31
490
0.62
1.91
1.8
2.2
8.15
9.60
ug/l
0.14
25
456
14
65
2.18
1.89
1.1
2.3
—
—
—
0
0
9
35
2.59
1.80
1.1
1.1
—
—
—
0
0
170
1424
1.25
1.78
2.5
2.4
—
—
—
0
0
21
117
1.82
1.76
1.3
1.5
—
—
—
0
0
6
18
3.35
1.75
1.0
1.2
—
—
—
0
0
48
333
1.47
1.72
1.2
2.3
40.88
39.48
u/l
0.17
43
308
21
118
1.80
1.72
1.3
1.5
1.14
1.13
ratio
0.01
13
72
21
118
1.80
1.72
1.3
1.5
1.09
1.23
ratio
0.36
13
72
21
118
1.80
1.72
1.3
1.5
0.77
0.97
ratio
3.05
13
72
10
40
2.52
1.67
1.0
1.1
—
—
—
0
0
14
69
2.05
1.65
1.1
1.2
—
—
—
0
0
14
69
2.05
1.65
1.7
1.3
—
—
—
0
0
13
63
2.08
1.60
1.2
1.1
—
—
—
0
0
171
1452
1.23
1.58
1.9
1.9
2.13
1.11
mg/l
0.53
137
1113
130
1075
1.25
1.52
2.6
4.1
0.83
0.82
mmol/l
0.13
120
1033
246
2760
0.84
1.49
2.8
2.8
—
—
estimate
—
0
0
10
45
2.24
1.47
1.2
1.3
0.69
0.53
ratio
—
5
25
83
1043
0.77
1.46
1.6
1.7
410.79
28804776.88
pmol/l
0.97
73
920
7
28
2.51
1.45
1.6
2.1
—
—
—
0
0
7
28
2.51
1.45
1.6
2.1
—
—
—
0
0
307
2774
1.18
1.45
2.9
3.0
167.73
149.89
ug/l
0.24
299
2657
6
22
2.74
1.43
1.2
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
166
1.59
1.39
2.3
3.5
0.50
0.33
iu/ml
—
9
88
95
1166
0.79
1.38
1.3
1.3
24.47
25.66
iu/ml
0.04
22
344
29
428
0.66
1.36
2.6
3.3
4.82
5.15
kpa
2.85
29
417
20
120
1.69
1.35
1.4
1.2
2.93
3.89
u/ml
0.46
15
57
0
38
0.00
1.34
0.0
1.1
—
100.50
—
0
30
0
39
0.00
1.34
0.0
1.9
—
0.44
—
0
10
23
144
1.62
1.33
1.5
1.5
15391.25
12597.24
e6/l
0.10
12
101
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
9
45
2.01
1.23
1.0
1.0
1700.33
1557.73
miu/ml
—
9
45
19
116
1.65
1.22
2.7
4.0
4.74
5.03
kpa
1.94
19
116
85
1037
0.80
1.19
1.4
1.3
16.58
8.82
u/ml
0.30
20
419
8
38
2.12
1.18
1.1
1.1
—
—
—
0
0
156
1787
0.84
1.17
2.2
2.7
362.12
356.87
umol/l
0.28
139
1656
10
51
1.97
1.11
1.1
1.1
—
—
—
0
0
10
51
1.97
1.11
1.1
1.1
—
—
—
0
0
7
33
2.13
1.05
2.7
2.0
—
411.80
—
0
5
23
154
1.51
1.04
1.8
2.5
163.60
150.22
ug/min
0.06
16
84
650
6332
1.23
1.02
19.2
16.4
3.91
3.98
mmol/l
10.12
640
6227
178
1996
0.86
1.02
2.5
2.7
0.67
0.67
ug/l
0.00
126
1023
14
83
1.70
1.02
1.0
2.2
—
—
—
0
0
30
214
1.42
1.01
1.4
1.3
—
—
—
0
0
13
76
1.72
0.99
1.1
1.1
—
—
—
0
0
0
29
0.00
0.98
0.0
3.3
—
1.34
—
0
29
14
85
1.66
0.95
1.1
1.4
—
—
—
0
0
19
125
1.53
0.94
1.4
1.3
1.45
4.59
u/ml
1.10
11
46
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
37
1.90
0.94
1.0
1.2
—
—
—
0
0
6
27
2.23
0.93
1.2
1.0
—
—
—
0
0
8
43
1.87
0.87
1.0
1.8
3.40
4.10
mg/l
—
8
43
200
1813
1.14
0.85
4.8
3.5
2.36
2.35
mmol/l
0.91
183
1693
12
191
0.62
0.85
1.5
2.0
—
—
—
0
0
68
563
1.23
0.84
2.0
2.0
47.84
36.93
nmol/l
2.18
68
550
10
57
1.76
0.84
1.1
1.1
—
—
—
0
0
12
188
0.63
0.80
2.4
2.7
6859.60
3526.61
u/l
—
5
65
0
25
0.00
0.79
0.0
3.4
—
59.18
—
0
25
109
951
1.17
0.78
3.1
3.0
2.45
2.43
mmol/l
0.84
92
864
14
90
1.57
0.78
1.1
1.1
—
—
—
0
0
0
27
0.00
0.77
0.0
1.2
—
9.12
—
0
27
136
1520
0.87
0.75
2.6
3.3
844.94
996.23
ng/l
0.39
121
1258
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
26
344
0.75
0.73
2.3
3.9
4.45
4.68
pmol/l
0.64
21
313
12
183
0.65
0.73
1.4
1.8
—
—
—
0
0
6
108
0.55
0.73
1.0
1.7
—
—
—
0
0
6
108
0.55
0.73
1.2
1.4
—
—
—
0
0
644
6308
1.17
0.70
18.3
16.3
139.24
139.72
mmol/l
6.40
637
6211
7
41
1.71
0.70
1.0
1.2
—
—
—
0
0
9
58
1.56
0.70
1.0
1.2
—
—
—
0
0
27
352
0.76
0.69
2.3
3.4
-0.13
1.55
mmol/l
3.10
17
261
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
5
28
1.79
0.66
1.0
2.2
—
—
—
0
0
7
113
0.62
0.58
1.7
3.9
9.27
9.47
pmol/l
—
7
113
16
115
1.40
0.57
1.0
1.1
—
—
—
0
0
127
1397
0.89
0.56
5.2
3.2
1.02
1.02
kg/l
1.02
94
894
6
39
1.54
0.53
1.0
1.3
—
—
—
0
0
9
134
0.67
0.52
1.4
1.6
—
—
—
0
0
7
46
1.53
0.48
1.3
2.3
97.86
91.85
%
—
7
46
7
47
1.49
0.47
1.0
1.6
5.13
8.08
u/l
—
7
39
79
704
1.14
0.47
18.1
11.7
0.07
0.97
mmol/l
1.23
66
587
7
48
1.46
0.47
1.0
1.3
—
—
—
0
0
13
175
0.74
0.45
1.2
1.8
—
—
—
0
0
9
131
0.68
0.43
1.3
1.3
—
277.14
—
0
7
0
15
0.00
0.41
0.0
8.5
—
11.13
—
0
15
0
16
0.00
0.41
0.0
2.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
551
5618
0.92
0.40
4.4
4.4
1.83
1.82
mu/l
0.07
533
5306
20
160
1.26
0.39
1.1
2.0
—
—
—
0
0
16
126
1.28
0.35
1.5
1.5
—
—
—
0
0
10
73
1.37
0.34
1.0
1.2
—
—
—
0
0
16
127
1.27
0.33
1.1
1.1
—
1.77
—
0
10
446
4565
0.94
0.33
3.1
3.7
13.88
14.57
pmol/l
8.69
427
4287
6
47
1.28
0.32
1.2
1.2
91.00
109.17
pmol/l
—
6
47
132
1240
1.08
0.31
2.2
2.1
1.62
1.48
%
1.63
117
1119
7
96
0.73
0.31
1.3
1.3
7.56
7.18
mmol/l
—
7
87
10
75
1.34
0.30
1.1
1.5
—
—
—
0
0
34
297
1.15
0.30
1.5
1.6
271.15
257.39
mu/l
0.28
34
278
10
76
1.32
0.28
1.1
1.5
—
—
—
0
0
10
76
1.32
0.28
1.1
1.5
—
—
—
0
0
5
75
0.66
0.26
3.0
3.2
3.08
3.19
nmol/l
—
5
75
44
487
0.90
0.26
1.7
1.5
—
—
—
0
0
9
73
1.24
0.25
1.1
1.5
—
—
—
0
0
9
74
1.22
0.25
1.1
1.5
—
—
—
0
0
9
74
1.22
0.25
1.1
1.5
—
—
—
0
0
7
92
0.76
0.22
1.1
1.6
—
—
—
0
0
10
124
0.80
0.21
1.3
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
2.76
—
0
5
0
12
0.00
0.21
0.0
1.3
—
214.70
—
0
7
0
12
0.00
0.21
0.0
2.3
—
39.25
—
0
12
15
126
1.19
0.21
1.4
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
1.22
—
0
13
15
176
0.85
0.20
1.1
1.1
—
6.18
—
0
24
18
155
1.17
0.20
1.3
1.3
—
—
—
0
0
36
327
1.11
0.19
1.3
1.5
10.70
6.49
u/l
0.68
21
266
20
227
0.88
0.18
2.6
2.5
22.90
24.57
mmol/l
1.71
20
227
7
58
1.21
0.18
1.1
2.2
—
—
—
0
0
19
168
1.13
0.16
1.5
2.4
20.89
34.86
u/ml
0.98
19
161
9
80
1.13
0.15
1.2
2.1
—
—
—
0
0
33
307
1.08
0.12
1.2
1.4
16.92
21.08
iu/l
0.43
20
255
14
124
1.13
0.11
1.3
1.2
114.64
113.78
%
0.04
14
115
12
106
1.13
0.10
1.1
2.3
—
—
—
0
0
12
107
1.12
0.08
1.0
1.1
—
—
—
0
0
35
332
1.06
0.08
1.1
1.1
—
—
—
0
0
32
338
0.94
0.08
2.1
2.7
0.55
0.62
%
0.62
32
338
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
7
65
1.08
0.08
1.1
2.1
—
—
—
0
0
28
297
0.94
0.08
1.4
1.4
—
—
—
0
0
7
66
1.06
0.08
1.9
2.7
3.01
6.74
umol/l
—
7
52
17
157
1.08
0.07
1.2
1.8
—
—
—
0
0
9
85
1.06
0.07
1.1
1.4
61.67
248.27
pmol/l
—
9
80
14
128
1.10
0.06
1.3
1.2
—
—
—
0
0
12
129
0.93
0.03
1.3
1.8
—
—
—
0
0
16
151
1.06
0.03
1.0
1.2
—
52.68
—
0
14
18
171
1.05
0.03
1.2
2.0
—
—
—
0
0
19
199
0.95
0.03
1.1
1.2
—
25.59
—
0
7
37
378
0.98
0.01
2.1
2.8
198.13
136.78
ng/l
0.31
32
334
18
173
1.04
0.01
1.1
1.2
—
—
—
0
0
13
126
1.03
0.00
1.4
1.4
187.29
168.76
pmol/l
0.25
13
126
14
138
1.01
0.00
2.3
2.7
9.29
8.25
kpa
1.27
14
138
39
388
1.01
0.00
1.1
1.2
160.43
124.40
u/ml
—
7
149
14
139
1.01
0.00
1.1
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
0.38
—
0
8
0
7
0.00
-0.00
0.0
1.7
—
1.43
—
0
7
0
7
0.00
-0.00
0.0
5.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.1
—
1.17
nmol/l
—
0
12
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
1.23
—
0
7
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
435.60
—
0
5
0
5
0.00
-0.00
0.0
6.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
2.18
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.16
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
1336.00
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_HIV_WIDE – Human immunodeficiency virus [HIV] disease, including avohilmo
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).